Related Experiment Video
Updated: Aug 9, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Gut microbiome composition is associated with long-term disability worsening in multiple sclerosis
Lindsay Devolder1,2,3, Ayla Pauwels1,2,3,4,5, Ann Van Remoortel5
1Laboratory of Molecular Bacteriology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium.
Abstract:
Predicting the long-term outcome of multiple sclerosis (MS) remains an important challenge to this day. As the gut microbiota is emerging as a potential player in MS, we investigated in this study whether gut microbial composition at baseline is related to long-term disability worsening in a longitudinal cohort of 111 MS patients. Fecal samples and extensive host metadata were collected at baseline and 3 months post-baseline, with additional repeated neurological measurements performed over (median) 4.4 y. Worsening (with EDSS-Plus) occurred in 39/95 patients (outcome undetermined for 16 individuals). The inflammation-associated, dysbiotic Bacteroides 2 enterotype (Bact2) was detected at baseline in 43.6% of worsened patients, while only 16.1% of non-worsened patients harbored Bact2. This association was independent of identified confounders, and Bact2 was more strongly associated with EDSS-Plus than neurofilament light chain (NfL) plasma levels. Furthermore, using fecal sampling performed 3 months post-baseline, we observed Bact2 to be relatively stable, suggesting its potential use as a prognostic biomarker in MS clinical practice.
Insights
The gut microbe Bacteroides 2 enterotype (Bact2) is linked to worsening disability in multiple sclerosis (MS) patients. This finding suggests Bact2 could serve as a prognostic biomarker for MS progression.
Area of Science:
- Microbiome research
- Neurology
- Immunology
Background:
- Predicting long-term outcomes in multiple sclerosis (MS) is challenging.
- The gut microbiota is increasingly recognized for its role in MS pathogenesis.
- Understanding gut microbial influences can aid in MS management.
Purpose of the Study:
- To investigate the association between gut microbial composition at baseline and long-term disability worsening in MS patients.
- To evaluate the potential of specific microbial profiles as prognostic biomarkers for MS.
- To determine if gut microbial composition predicts disease progression over time.
Main Methods:
- Longitudinal cohort study of 111 MS patients.
- Collection of fecal samples and host metadata at baseline and 3 months.
- Neurological measurements, including EDSS-Plus, performed over a median of 4.4 years.
- Analysis of gut microbial composition, focusing on the Bacteroides 2 enterotype (Bact2).
Main Results:
- Worsening disability (EDSS-Plus) occurred in 39/95 patients.
- The inflammation-associated Bacteroides 2 enterotype (Bact2) was significantly more prevalent in patients with worsening disability (43.6%) compared to non-worsened patients (16.1%).
- Bact2 association with EDSS-Plus was independent of confounders and stronger than plasma NfL levels.
- Bact2 demonstrated relative stability over 3 months, indicating its potential as a biomarker.
Conclusions:
- Gut microbial dysbiosis, specifically the Bacteroides 2 enterotype (Bact2), is associated with long-term disability worsening in multiple sclerosis.
- Bact2 shows potential as a stable and reliable prognostic biomarker for MS progression.
- These findings highlight the gut microbiome's role in MS and suggest new avenues for patient monitoring and therapeutic strategies.
More Related Videos
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Fungal Phylum Microsporidia

